Chief Executive Officer:
Ton Vries, PhD
Ton Vries has been Syncom’s CEO since 2000 when he succeeded Prof. Hans Wynberg, founder of Syncom. Since 1991 Ton has worked in various roles of increasing responsibility in Syncom as Research Chemist, Group Leader and Director of Research. He has been involved in many different aspects of Syncom business including scientific development, chiral technologies, business development and business strategy.
Ton obtained his MSc in 1988 and received his PhD in Organic Chemistry in the field of chiral resolutions in 1996 from the University of Groningen, The Netherlands.
Chief Operating Officer:
Robert Hof, PhD
Robert Hof carries over 20 years of leadership experience in R&D and BD positions in the pharmaceutical service industry. Robert joined Syncom in 2010 as Chief Operating Officer. Prior to joining Syncom he has worked 13 years for the pharma division of DSM where he held managerial responsibilities in the field of process R&D, cGMP manufacturing and innovation management. Robert has extensive experience in both small molecule as well as biopharmaceutical process development. Also, Robert has worked 2 years for Pepscan Therapeutics leading the CMC development of Pepscan’s therapeutic vaccine pipeline.
Robert obtained his MSc in 1990 and received his PhD in Organic Chemistry in 1995 from the University of Groningen, The Netherlands.